Earnings Call · Q1 FY2024·2024-05-06

Q1 24EPS -91.14%·Rev n/aQ4 23EPS -2.17%·Rev n/aQ3 23EPS +100.00%*·Rev n/aQ2 23EPS +17.20%·Rev n/a⚠ consensus missing

Travere Therapeutics, Inc. TVTX

Anne Crotteau — Manager of Investor Relations

Eric Dube — President and Chief Executive Officer

Unknown

Jula Inrig — Chief Medical Officer

Peter Heerma — Chief Commercial Officer

Chris Cline — Chief Financial Officer

+3.1%1d on move date+2.9% vs SPY3d+0.8%5d−3.2%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TVTX calls or request research access.

More TVTX calls Browse calls Request research access